{"id":4412,"date":"2025-03-31T18:12:07","date_gmt":"2025-03-31T18:12:07","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/tiludronic-acid-txt\/"},"modified":"2025-03-31T18:12:07","modified_gmt":"2025-03-31T18:12:07","slug":"tiludronic-acid-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/tiludronic-acid-txt\/","title":{"rendered":"Tiludronic acid.txt"},"content":{"rendered":"<p><H3>  CLINICAL USE <\/H3>  Paget\u2019s disease of bone <H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3> 400 mg daily for 12 weeks <H3>  PHARMACOKINETICS    <\/H3> <LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : 318.6 <\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : 91 <\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp : 60 <\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp : No data <\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp : &gt;100\/205 <H3>  DOSE IN RENAL IMPAIRMENT <\/H3> <H4>GFR (mL\/MIN)<\/H4> 60\u201390 Use with caution 30\u201360 Use with caution &lt;30 Avoid <H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3> <LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp: Unlikely to be dialysed. Avoid <\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : Unlikely to be dialysed. Avoid <LI>HDF\/high flux  &amp;nbsp : Unknown dialysability. Avoid <LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp: Unlikely to be dialysed. Avoid <H3> IMPORTANT DRUG INTERACTIONS  <\/H3> Potentially hazardous interactions with other drugs Calcium salts: reduced absorption   <H3> ADMINISTRATION  <\/H3> <H4> Reconstition<\/H4> \u2013 <H4>  Route  <\/H4> Oral   <H4>  Rate of Administration  <\/H4> \u2013 <H4>Comments<\/H4> \u2013 <H4>  OTHER INFORMATION  <\/H4> Take as a single dose with a glass of water   at least 2 hours before or after meals, calcium supplements or aluminium or magnesium containing antacids Patients should ensure their calcium and   vitamin D intake is adequate Calcium metabolism disorders should be   corrected before starting therapy Bisphosphonates are mainly eliminated by   excretion of unchanged drug in the urine .<br \/>\n","protected":false},"excerpt":{"rendered":"<p>CLINICAL USE Paget\u2019s disease of bone DOSE IN NORMAL RENAL<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-4412","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=4412"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/4412\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=4412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=4412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=4412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}